ATE312829T1 - Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide - Google Patents

Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide

Info

Publication number
ATE312829T1
ATE312829T1 AT02002815T AT02002815T ATE312829T1 AT E312829 T1 ATE312829 T1 AT E312829T1 AT 02002815 T AT02002815 T AT 02002815T AT 02002815 T AT02002815 T AT 02002815T AT E312829 T1 ATE312829 T1 AT E312829T1
Authority
AT
Austria
Prior art keywords
matrix
metalloproteinisters
usable
alkyl
tricyclic
Prior art date
Application number
AT02002815T
Other languages
English (en)
Inventor
Patrick Michael O'brien
William Chester Patt
Joseph Armand Picard
Kevon Ray Shuler
Drago Robert Sliskovic
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE312829T1 publication Critical patent/ATE312829T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02002815T 2001-02-14 2002-02-08 Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide ATE312829T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26873701P 2001-02-14 2001-02-14

Publications (1)

Publication Number Publication Date
ATE312829T1 true ATE312829T1 (de) 2005-12-15

Family

ID=23024247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02002815T ATE312829T1 (de) 2001-02-14 2002-02-08 Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide

Country Status (8)

Country Link
US (1) US6559142B2 (de)
EP (1) EP1233017B1 (de)
JP (1) JP2002308859A (de)
AT (1) ATE312829T1 (de)
BR (1) BR0200414A (de)
CA (1) CA2371481A1 (de)
DE (1) DE60207913D1 (de)
MX (1) MXPA01013172A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594459B1 (de) 2002-12-30 2010-02-17 Angiotech International Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
ES2537514T3 (es) 2003-04-04 2015-06-09 Incyte Corporation Composiciones, métodos y kits relacionados con la escisión de HER-2
JP2010507674A (ja) * 2006-10-27 2010-03-11 ワイス エルエルシー マトリクスメタロプロテアーゼ阻害剤としての三環式化合物
ES2529147T3 (es) * 2006-12-26 2015-02-17 Pharmacyclics, Inc. Método para usar los inhibidores de la histona deacetilasa y monitorear biomarcadores en la terapia de combinación
CL2008001257A1 (es) * 2007-05-04 2008-07-04 Wyeth Corp Compuestos triciclicos, inhibidores de metaloproteinasas matriciales; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, osteoartritis, aterosclerosis, cancer de pulmon, entre otras.
CN103917231B (zh) 2011-09-13 2016-09-28 药品循环有限责任公司 组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE213232T1 (de) * 1995-11-13 2002-02-15 Hoechst Ag Cyclische und heterocyclische n-substituierte alpha-iminohydroxam- und carbonsäuren
JP2000517341A (ja) 1996-09-04 2000-12-26 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼ阻害剤およびそれらの治療的使用
US6008243A (en) 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
IL128545A0 (en) 1996-12-09 2000-01-31 Warner Lambert Co Method for treating and preventing heart failure and ventricular dilatation
HUP0000657A3 (en) * 1997-02-11 2000-10-30 Pfizer N-arylsulfonyl-piperidine, -morpholine hydroxamic acid derivatives and pharmaceutical compositions containing them
US6934639B1 (en) 2000-02-25 2005-08-23 Wyeth Methods for designing agents that interact with MMP-13

Also Published As

Publication number Publication date
EP1233017B1 (de) 2005-12-14
DE60207913D1 (de) 2006-01-19
MXPA01013172A (es) 2002-08-21
US6559142B2 (en) 2003-05-06
BR0200414A (pt) 2003-04-29
CA2371481A1 (en) 2002-08-14
US20020169160A1 (en) 2002-11-14
EP1233017A1 (de) 2002-08-21
JP2002308859A (ja) 2002-10-23

Similar Documents

Publication Publication Date Title
ECSP055865A (es) Perindopril
NO20040100L (no) Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler
BR0207865A (pt) Benzotiadiazinas inibidores de metaloproteinases de matriz
HUP0302297A2 (hu) Szubsztituált tiocetamidok és ezeket tartalmazó gyógyászati készítmények
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
NO994482L (no) Visse cykliske tiosubstituerte acylaminosyreamidderivater
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
DE69426602D1 (de) 2,3-diaminopropionsäurederivate
ATE452889T1 (de) Die hiv-protease inhibierende sulfonamide
KR960007592A (ko) 신규한 피롤로카바졸
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
ATE312829T1 (de) Als matrix-metalloproteinasehemmer verwendbare tricyclische sulfonamide
ATE502005T1 (de) Amphotere lipidverbindung und deren verwendung
ATE380172T1 (de) Benzylaminanalogen
BRPI0416678A (pt) pirazolpirimidinas
EA200400666A2 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate
DK1312608T3 (da) Discodermolid-analoge samt deres farmaceutiske anvendelse
BR0201696A (pt) Compostos de alquilamida
TW200508211A (en) 2-naphthylimino-1,3-thiazine derivatives
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение
BR0312734A (pt) Composto de indolina e uso medicinal do mesmo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties